Inovio Pharmaceuticals Inc.

NAS: INO

GO
/marketstate/country/us

After Hours

 --Real time quotes

Jul 28, 2021, 4:11 p.m.

INO
/zigman2/quotes/202993817/composite

$

8.75

Change

+0.08 +0.92%

Volume

Volume 17,289

Real time quotes

/zigman2/quotes/202993817/composite

Today's close

$ 8.26

$ 8.67

Change

+0.41 +4.96%

Day low

Day high

$8.27

$8.74

Open

52 week low

52 week high

$5.81

$22.93

Open

Insider Actions for Inovio Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/09/2021 Peter D. Kies
CFO
33,750   Disposition at $10.01 per share. 337,837
06/09/2021 Laurent M. Humeau
Chief Scientific Officer
10,318   Disposition at $9.07 per share. 93,584
06/09/2021 Jacqueline E. Shea
Chief Operating Officer
38,535   Disposition at $10.01 per share. 385,735
06/09/2021 Peter D. Kies
CFO
13,750   Derivative/Non-derivative trans. at $2.16 per share. 29,700
06/03/2021 Peter D. Kies
CFO
10,000   Disposition at $8.03 per share. 80,300
05/17/2021 David B. Weiner
Director
3,045   Disposition at $6.62 per share. 20,157
05/17/2021 Simon X. Benito
Director
3,045   Disposition at $6.62 per share. 20,157
05/17/2021 Lota S. Zoth
Director
2,045   Disposition at $6.62 per share. 13,537
05/14/2021 David B. Weiner
Director
8,700   Derivative/Non-derivative trans. at $0 per share. 0
05/14/2021 Simon X. Benito
Director
8,700   Derivative/Non-derivative trans. at $0 per share. 0
05/14/2021 Wendy L. Yarno
Director
8,700   Derivative/Non-derivative trans. at $0 per share. 0
05/14/2021 Ann Calby Miller
Director
8,700   Derivative/Non-derivative trans. at $0 per share. 0
05/14/2021 Lota S. Zoth
Director
8,700   Derivative/Non-derivative trans. at $0 per share. 0
05/14/2021 Jay P. Shepard
Director
8,700   Derivative/Non-derivative trans. at $0 per share. 0
04/21/2021 David B. Weiner
Director
4,083   Disposition at $8.54 per share. 34,868
04/21/2021 David B. Weiner
Director
22,500   Disposition at $8.57 per share. 192,825
04/21/2021 Peter D. Kies
CFO
10,000   Disposition at $8.52 per share. 85,200
04/21/2021 David B. Weiner
Director
22,500   Derivative/Non-derivative trans. at $2.4 per share. 54,000
04/16/2021 Simon X. Benito
Director
2,000   Disposition at $8.75 per share. 17,500
04/16/2021 Simon X. Benito
Director
2,000   Derivative/Non-derivative trans. at $3.56 per share. 7,120
03/26/2021 Jacqueline E. Shea
Chief Operating Officer
4,710   Disposition at $8.97 per share. 42,248
03/25/2021 Jacqueline E. Shea
Chief Operating Officer
7,247   Derivative/Non-derivative trans. at $9.06 per share. 65,657
03/25/2021 Jacqueline E. Shea
Chief Operating Officer
16,667   Derivative/Non-derivative trans. at $0 per share. 0
03/21/2021 Ann Calby Miller
Director
4,274   Derivative/Non-derivative trans. at $0 per share. 0
03/16/2021 Simon X. Benito
Director
2,000   Disposition at $10.41 per share. 20,820
03/16/2021 Simon X. Benito
Director
2,000   Derivative/Non-derivative trans. at $3.56 per share. 7,120

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
7 Purchases
7 Sales
65,950
100,738
Last 6 months
28 Purchases
32 Sales
834,164
668,564
Last 12 months
38 Purchases
44 Sales
994,492
933,757

Officers and Executives

Dr. J. Joseph Kim
President, Chief Executive Officer & Director
Dr. Jacqueline E. Shea
Chief Operating Officer & Executive Vice President
Mr. Peter D. Kies
Chief Financial Officer
Dr. Kate E. Broderick
Senior Vice President-Research & Development
Dr. Mammen P. Mammen
Senior Vice President-Clinical Development
Mr. Stephen Kemmerrer
Senior Vice President-Engineering Development
Dr. Laurent M. Humeau
Chief Scientific Officer
Ms. Jessica C. Lee
VP-Clinical Operations & Global Integration
Ms. Maggie Campbell
Director-Finance
Dr. Jeffrey Skolnik
Senior Vice President-Clinical Development
Mr. Shawn D. Bridy
Vice President-Business Development
Mr. Mark C. Twyman
Senior Vice President-Commercial
Dr. Roger D. Dansey
Director
Dr. David B. Weiner
Director
Mr. Ben Matone
Director-Investor Relations
Dr. Ami Shah Brown
Vice President-Regulatory Affairs
Mr. Simon X. Benito
Chairman
Mr. Jay P. Shepard
Independent Director
Ms. Wendy L. Yarno
Independent Director
Ms. Lota S. Zoth
Independent Director
Dr. Ann Calby Miller
Independent Director
Link to MarketWatch's Slice.